Kaya Y, Aki OE, Can UA, Derle E, Kibaroğlu S, Barak A (2014) Validation of Montreal Cognitive Assessment and discriminant power of Montreal cognitive assessment subtests in patients with mild cognitive impairment and Alzheimer dementia in Turkish population. Ng TP, Feng L, Lim WS, Chong MS, Lee TS, Yap KB, Tsoi T, Liew TM, Gao Q, Collinson S, Kandiah N, Yap P (2015) Montreal Cognitive Assessment for screening mild cognitive impairment: variations in test performance and scores by education in Singapore. Rossetti HC, Lacritz LH, Cullum CM, Weiner MF (2011) Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample. Lu J, Li D, Li F, Zhou A, Wang F, Zuo X, Jia XF, Song H, Jia J (2011) Montreal cognitive assessment in detecting cognitive impairment in Chinese elderly individuals: a population-based study. Rouleau I, Salmon DP, Butters N, Kennedy C, McGuire K (1992) Quantitative and qualitative analyses of clock drawings in Alzheimer’s and Huntington’s disease. Appl Neuropsychol 7:243–246Ĭheung RW, Cheung MC, Chan AS (2004) Confrontation naming in Chinese patients with left, right or bilateral brain damage. Lu L, Bigler ED (2000) Performance on original and a Chinese version of trail making test part B: a normative bilingual sample. Neurology 43:2412–2414ĭai XY, Ryan JJ, Paolo AM, Harrington RG (1990) Factor analysis of the mainland Chinese version of the Wechsler Adult Intelligence Scale (WAIS-RC) in a brain-damaged sample. Morris JC (1993) The Clinical Dementia Rating (CDR): current version and scoring rules. Osterrieth PA (1944) Le test de copie d’une figure complexe. Strauss E, Sherman EM, Spreen O (2006) A compendium of neuropsychological tests: administration, norms, and commentary, 3rd edn. Petersen RC (2004) Mild cognitive impairment as a diagnostic entity. Zhang M, Katzman R, Salmon D, Jin H, Cai GJ, Wang ZY, Qu GY, Grant I, Yu E, Levy P (1990) The prevalence of dementia and Alzheimer’s disease in Shanghai, China: impact of age, gender, and education. Nasreddine Z, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Intern Med 275:214–228īusse A, Hensel A, Gühne U, Angermeyer MC, Riedel-Heller SG (2006) Mild cognitive impairment: long-term course of four clinical subtypes. Petersen RC, Caracciolo B, Brayne C, Gauthier S, Jelic V, Fratiglioni L (2014) Mild cognitive impairment: a concept in evolution. Petersen RC, Roberts RO, Knopman DS, Boeve BF, Geda YE, Ivnik RJ, Smith GE, Jack CR Jr (2009) Mild cognitive impairment: ten years later. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B (2001) Current concepts in mild cognitive impairment. Jia J, Wang F, Wei C, Zhou A, Jia X, Li F, Tang M, Chue L, Zhou Y, Zhou C, Cui Y, Wang Q, Wang W, Yin P, Hu N, Zuo X, Song H, Qin W, Wu L, Li D, Jia L, Song J, Han Y, Xing Y, Yang P, Li Y, Qiao Y, Tang Y, Lv J, Dong X (2014) The prevalence of dementia in urban and rural areas of China. The MoCA is a good screening tool for detecting different types of MCI and is suitable for patients in outpatient clinics. Delayed free recall or category prompted recall in the MoCA had roles in differentiating asMCI and controls groups with AUC value of 0.717 ( p = 0.002) and 0.691 ( p = 0.005), respectively. The AUC value decreased to 0.687 when applied to the naMCI and control groups ( p = 0.007), which was still higher than that of the Rey Auditory Verbal Learning Test (RAVLT) or the Rey-Osterrieth complex figure (ROCF). The area under the curve (AUC) value for the MoCA when comparing the amMCI and control groups was 0.884 ( p < 0.001), which was superior to that of the MMSE. Patients with amMCI performed worse than patients with asMCI, naMCI, and healthy controls on the MMSE and the MoCA ( p < 0.001).

All participants were administered by the Mini Mental State Examination (MMSE) and the MoCA. Fifty-six aMCI-multiple domains (amMCI), 32 aMCI-single domain (asMCI), and 33 naMCI patients were diagnosed according to extensive cognitive tests. A total of 121 patients with MCI and 53 healthy controls were included. To investigate the role of the Montreal Cognitive Assessment (MoCA) (Beijing version) and its memory tasks on detecting different mild cognitive impairment (MCI) subtypes including amnestic MCI (aMCI) and nonamnestic MCI (naMCI) in memory clinics.

Moca memodry test pdf